193 related articles for article (PubMed ID: 29799517)
21. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
[TBL] [Abstract][Full Text] [Related]
22. A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis.
Furlan R; Kurne A; Bergami A; Brambilla E; Maucci R; Gasparini L; Butti E; Comi G; Ongini E; Martino G
J Neuroimmunol; 2004 May; 150(1-2):10-9. PubMed ID: 15081244
[TBL] [Abstract][Full Text] [Related]
23. RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease.
Jahagirdar R; Attwell S; Marusic S; Bendele A; Shenoy N; McLure KG; Gilham D; Norek K; Hansen HC; Yu R; Tobin J; Wagner GS; Young PR; Wong NCW; Kulikowski E
Mol Pharmacol; 2017 Dec; 92(6):694-706. PubMed ID: 28974538
[TBL] [Abstract][Full Text] [Related]
24. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
[TBL] [Abstract][Full Text] [Related]
25. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy.
Burton BR; Britton GJ; Fang H; Verhagen J; Smithers B; Sabatos-Peyton CA; Carney LJ; Gough J; Strobel S; Wraith DC
Nat Commun; 2014 Sep; 5():4741. PubMed ID: 25182274
[TBL] [Abstract][Full Text] [Related]
26. Stimulation with FITC-labeled antigens confers B cells with regulatory properties.
Planchais C; Rayes J; Delignat S; Pashova S; Varthaman A; Pashov A; Bayry J; Kaveri SV; Dimitrov JD; Lacroix-Desmazes S
Cell Immunol; 2020 Sep; 355():104151. PubMed ID: 32615414
[TBL] [Abstract][Full Text] [Related]
27. Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase.
Hao W; Luo Q; Menger MD; Fassbender K; Liu Y
Front Immunol; 2021; 12():792465. PubMed ID: 34975892
[TBL] [Abstract][Full Text] [Related]
28. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
29. ZSTK474, a novel PI3K inhibitor, modulates human CD14+ monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis.
Xue Z; Li W; Wang H; Huang B; Ge Z; Gu C; Liu Y; Zhang K; Yang J; Han R; Peng M; Li Y; Zhang D; Da Y; Yao Z; Zhang R
J Mol Med (Berl); 2014 Oct; 92(10):1057-68. PubMed ID: 24844601
[TBL] [Abstract][Full Text] [Related]
30. Amelioration of experimental autoimmune encephalomyelitis by the quinoline-3-carboxamide paquinimod: reduced priming of proinflammatory effector CD4(+) T cells.
Helmersson S; Sundstedt A; Deronic A; Leanderson T; Ivars F
Am J Pathol; 2013 May; 182(5):1671-80. PubMed ID: 23506849
[TBL] [Abstract][Full Text] [Related]
31. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
Imler TJ; Petro TM
Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
[TBL] [Abstract][Full Text] [Related]
32. Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
Oh K; Park HB; Seo MW; Byoun OJ; Lee DS
Clin Immunol; 2012 Nov; 145(2):122-32. PubMed ID: 23001131
[TBL] [Abstract][Full Text] [Related]
33. ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.
Aragoneses-Fenoll L; Montes-Casado M; Ojeda G; Acosta YY; Herranz J; Martínez S; Blanco-Aparicio C; Criado G; Pastor J; Dianzani U; Portolés P; Rojo JM
Biochem Pharmacol; 2016 Apr; 106():56-69. PubMed ID: 26883061
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells.
Varga G; Ehrchen J; Tsianakas A; Tenbrock K; Rattenholl A; Seeliger S; Mack M; Roth J; Sunderkoetter C
J Leukoc Biol; 2008 Sep; 84(3):644-50. PubMed ID: 18611985
[TBL] [Abstract][Full Text] [Related]
35. FAS/FAS-L dependent killing of activated human monocytes and macrophages by CD4+CD25- responder T cells, but not CD4+CD25+ regulatory T cells.
Jagger AL; Evans HG; Walter GJ; Gullick NJ; Menon B; Ballantine LE; Gracie A; Magerus-Chatinet A; Tiemessen MM; Geissmann F; Rieux-Laucat F; Taams LS
J Autoimmun; 2012 Feb; 38(1):29-38. PubMed ID: 22197557
[TBL] [Abstract][Full Text] [Related]
36. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.
Weber MS; Prod'homme T; Patarroyo JC; Molnarfi N; Karnezis T; Lehmann-Horn K; Danilenko DM; Eastham-Anderson J; Slavin AJ; Linington C; Bernard CC; Martin F; Zamvil SS
Ann Neurol; 2010 Sep; 68(3):369-83. PubMed ID: 20641064
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor.
Dai H; Ciric B; Zhang GX; Rostami A
J Neuroimmunol; 2012 Apr; 245(1-2):1-7. PubMed ID: 22365083
[TBL] [Abstract][Full Text] [Related]
38. Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis.
Li YH; Yu JZ; Liu CY; Zhang H; Zhang HF; Yang WF; Li JL; Feng QJ; Feng L; Zhang GX; Xiao BG; Ma CG
Immunology; 2014 Oct; 143(2):219-29. PubMed ID: 24749492
[TBL] [Abstract][Full Text] [Related]
39. B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs.
Petersen J
Dan Med Bull; 1988 Apr; 35(2):140-57. PubMed ID: 3282810
[TBL] [Abstract][Full Text] [Related]
40. Decrease of CD68 Synovial Macrophages in Celastrol Treated Arthritic Rats.
Cascão R; Vidal B; Lopes IP; Paisana E; Rino J; Moita LF; Fonseca JE
PLoS One; 2015; 10(12):e0142448. PubMed ID: 26658436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
